Effect of lovastatin on serum lipid and apolipoprotein levels after dietary fat load in patients with ischemic heart disease
Perova, N.V.; Bubnova, M.G.; Aronov, D.M.; Zhidko, N.I.; Olferév, A.M.; Akhmedzhanov, N.M.
Kardiologiia 33(4): 8-10
1993
ISSN/ISBN: 0022-9040 PMID: 7933801 Document Number: 421225
Document emailed within 1 workday
Related Documents
Poliakova, E.D.; Ivanova, T.N.; Nikulina, S.E.; Metel'skaia, V.A.; Olfer'ev, A.M.; Shcherbakova, I.A.; Akhmedzhanov, N.M.; Perova, N.V. 1994: Changes in the rate of cholesterol synthesis in lymphocytes, and blood lipid and lipoprotein levels in patients with ischemic heart disease and hypercholesterolemia during treatment with lovastatin and obsidan Biulleten' Eksperimental'noi Biologii i Meditsiny 117(3): 248-251Ianovskiĭ, G.V.; Solovtsova, K.M. 1979: Physical load tolerance and lipid metabolic indices in patients with the initial manifestations of ischemic heart disease Kardiologiia 19(9): 74-78
Kusá, O. 1976: Diabetes mellitus as risk factor of ischemic heart disease and reflected in serum lipid levels Bratislavske Lekarske Listy 66(1): 28-37
Chursina, T.V.; Molchanov, A.V.; Mikhin, V.P. 2007: Lipid peroxidation and antioxidant defense in patients with ischemic heart disease: correction with free-load bicycle exercise Terapevticheskii Arkhiv 79(1): 48-52
Idzior-Waluś, B. 1992: Influence of lovastatin on serum lipids in patients with primary hyperlipidemia and phenotype IIa and IIB. II. Changes of lipid composition of plasma lipoprotein fractions after lovastatin administration Przeglad Lekarski 49(10): 327-333
Samsonov, M.A.; Vasil'ev, A.V.; Pogozheva, A.V.; Pokrovskaia, G.R.; Mal'tsev, G.I.; Biiasheva, I.R.; Orlova, L.A. 1992: The effect of a soy protein isolate and sources of polyunsaturated omega-3 fatty acids in an anti-atherosclerotic diet on the lipid spectrum of blood serum and immunological indicators in patients with ischemic heart disease and hypertension Voprosy Meditsinskoi Khimii 38(5): 47-50
Haviar, V.; Riecanský, L.; Kusá, O.; Luknárová, O. 1972: Effects of heparin and clofibrate on blood-serum lipid levels in patients with ischaemic heart disease Cor et Vasa 14(3): 188-196
Sánchez, T.; Contreras-Yáñez, Iú.; Elías-López, D.; Aguilar Salinas, C.A.; Pascual-Ramos, V. 2014: Prevalence of lipid phenotypes, serum lipid behaviour over follow-up and predictors of serum lipid levels in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease-modifying anti-rheumatic drugs Clinical and Experimental Rheumatology 32(4): 509-515
Amosova, E.N.; Bereza, N.V.; Potapkova, I.V. 2002: Effect of complex therapy including ATP-long on left ventricular diastolic function in patients with ischemic heart disease at rest and under isometric load Likars'ka Sprava 2002(3-4): 48-51
Gorbachev, V.V.; Pristrom, M.S. 1983: The effect of anapriline on the thyroid function and lipid metabolism in ischemic heart disease in elderly patients Terapevticheskii Arkhiv 55(5): 53-56
Gavrilova, R.D.; Khanina, S.B.; Simonov, V.V.; Puntus, K.K.; Zybin, O.K. 1987: Blood lipid levels in various forms of ischemic heart disease Kardiologiia 27(10): 51-55
Liusov, V.A.; Gorbachenkov, A.A.; Dudaev, V.A.; Gorin, V.V. 1992: The effect of bee honey and flower pollen on the tolerance for physical loads, on lipid metabolism and on the rheological properties of the blood in patients with ischemic heart disease Kardiologiia 32(7-8): 45-48
Zhu, T.; Wang, Z.; Zhao, S. 1998: Effect of apolipoprotein e gene plasma levels of lipids, lipoproteins, apolipoproteins and its relation with coronary heart disease Hunan Yi Ke da Xue Xue Bao 23(2): 149-151
Fu, M.; Liu, B.; Wu, Z.; Fan, P.; Xie, G.; Liu, Y.; Zhang, R. 1997: The serum lipid and apolipoprotein levels of middle-aged male hyperlipidemics in Chengdu district Hua Xi Yi Ke Da Xue Xue Bao 28(1): 10-13
Cherkanova, M.S.; Korolenko, T.A.; Bravve, I.I.; Gerasimova, T.P. 2012: Effect of statins on activity of matrix metalloproteases and serum concentration of cystatin C in patients with various risk of development of ischemic heart disease and in patients after coronary artery bypass surgery Kardiologiia 52(2): 23-28
Shustval', N.F. 1992: The effect of thymalin on lipid metabolism and the clinical course of ischemic heart disease Likars'ka Sprava 9: 73-76
Pogozheva, A.V.; Pavliuchkova, M.S.; Miagkova, M.A. 2002: Effect of an anti-atherogenic diet, including soy protein products with various levels of phytoestrogens, on indicators of humoral immunity in patients with hypertension and ischemic heart disease Voprosy Pitaniia 71(3): 8-11
Xu, J.M.; Cai, P.Y. 1986: A study on the relation between phlegm-stagnant type coronary heart disease and serum lipid levels Journal of Traditional Chinese Medicine 6(3): 183-186
Ferranti, E.; Latini, S.; Liberatore, M.; Scopinaro, F.; Iacovoni, P. 1983: Serum digoxin levels and echocardiographic indices of myocardial contractility in acute ischemic heart disease La Clinica Terapeutica 104(6): 473-477
Furkalo, N.K.; Kuchuk, A.A.; Nikishin, L.F. 1980: Evaluation criteria for load tests with ischemic heart disease patients with intact coronary arteries and with ones affected by arteriosclerosis Kardiologiia 20(3): 20-24